News

Mylan submits ANDA for generic Advair Diskus

BY DSN STAFF

PITTSBURGH — Mylan on Tuesday announced that it had submitted to the Food and Drug Administration an abbreviated new drug application (ANDA) for Advair Diskus (fluticasone propionate and salmeterol inhalation powder). 
 
The drug is intended to treat asthma and the maintenance of airflow obstruction and reducing exacerbations among patients with chronic obstructive pulmonary disease. Mylan said it would provide updates as the approval process continues. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

ICSC: Omnichannel wins, with physical stores at epicenter

BY Marianne Wilson

NEW YORK — A just-released holiday survey reinforces the dominance of the omnichannel shopper.
 
Nearly one-third (32%) of shoppers the past holiday season used the click and collect method – with 69% of these shoppers purchasing additional items in the store when they went to pick up the item and 36% making another purchase in an adjacent store, according to the International Council of Shopping Centers’ Holiday Consumer Purchasing Trends study.
 
What’s more, 60% of holiday shoppers used their mobile device while shopping in a store to do such things as compare prices, check availability and view reviews/ratings. And 56% of holiday shoppers researched products before they even entered the store.
 
"Looking back at the holiday season, the major trend that emerged is the prevalence of the omnichannel consumer and the resulting convergence among brick and mortar and digital retail," said Tom McGee, president and CEO of ICSC. "The story of bricks vs. clicks is an old one. The story is now one of a shopper getting the best of both worlds, using online research and capabilities to inform physical purchases.
 
Brick-and-mortar also fared well in the survey, which reported that 91% of consumers shopped in physical stores during the holiday season. Seeing, touching, and trying on merchandise was cited the number one reason to shop in store (32%), followed by the ability to browse (26%), and the ability to get the item right away (24%).
 
“The American consumer has sent a clear message that the physical store remains at the epicenter of the shopping experience,” McGee said.
 
In other survey findings:
  • Forty percent of shoppers say they spent more this season than in 2014, with 33% spending the same this season. Only 23% said they spent less than last year.
  • Shoppers like the ease of returning and exchanging products in store, with 20% of shoppers electing to shop in-store because of this advantage.
  • On average, 62% of holiday shoppers spent on gift cards, with an average spend of $145.  Of those that received a gift card, February or later (43%) is the most likely time for them to redeem it, followed by January (39%) and the last week of December (18%).
  • Forty-eight percent of holiday shoppers made a purchase in the apparel/footwear and electronics/devices categories this holiday season.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Galderma adds new president, general manager of North American business

BY David Salazar

FORT WORTH, Texas — Galderma Labs on Monday announced that it had promoted Miles Harrison to be president and general manager of Galderma’s North American branch, heading up its U.S. and Canada teams.  
 
“Galderma is experiencing a tremendous amount of growth following the launch of eight new products across all three business units in the U.S. over the past 18 months,” Galderma PharStuart Raetzman, Chief Executive Officer of Galderma Pharma S.A.  “Miles has the vision and experience to lead our organization at this exciting time of rapid and sustainable growth.”
 
Harrison joined Galderma U.S. in 2014 from Novartis as VP and general manager, self-medication business unit, which includes Cetaphil. During his tenure in that position, the division has launched several new products, including Excipal Skin Solutions, as well as men and baby lines of Cetaphil. Galderma’s North American operations are centered around three units: self-medication business, aesthetic and corrections and the prescription business, which includes the company’s Epiduo Gel and Epiduo Forte Gel.
 
“I am honored to take this leadership position at a time when Galderma is experiencing such fantastic growth and transformation,” Harrison said. "I am proud to be part of a company consistently trusted by doctors and patients that is truly changing people's lives with its solutions for skin health. We are committed to meeting the dermatological needs of people throughout their lives and we will continue to deliver innovative medical solutions to healthcare professionals, patients and consumers."
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?